Wolfe Repass sells FLD shares across Feb–Mar dates (FLD)

Rhea-AI Filing Summary

FLD reports proposed insider sales under Form 144 by Wolfe Repass. The notice lists multiple dispositions of Common shares between 02/19/2026 and 03/20/2026, with individual trades such as 21,857 shares for $32,427.05 on 02/19/2026. The filing also records Restricted Stock Vesting of 1,326 shares on 04/01/2026 tied to compensation.

Insights

Insider Transactions Analyst

Multiple small open-market dispositions were reported by an insider across several dates.

The excerpt lists sequential sales by Wolfe Repass with precise share counts and proceeds for each trade; these are routine dispositions reported via Form 144 and tied to a compensation-related vesting event on 04/01/2026.

Impact appears limited: transactions are modest in scale individually and the filing does not state larger structural changes. Subsequent filings may provide updated holdings or larger dispositions.

Key Figures

Sale on 02/19/2026: 21,857 shares Sale on 02/20/2026: 12,406 shares Restricted Stock Vesting: 1,326 shares

3 metrics

Sale on 02/19/2026 21,857 shares Proceeds $32,427.05 on 02/19/2026

Sale on 02/20/2026 12,406 shares Proceeds $19,179.67 on 02/20/2026

Restricted Stock Vesting 1,326 shares Vesting recorded 04/01/2026 as compensation

Key Terms

Restricted Stock Vesting, Compensation, Securities To Be Sold

3 terms

Restricted Stock Vesting financial

"Common | 04/01/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Compensation financial

"1326 | 04/01/2026 | Compensation"

Securities To Be Sold regulatory

"144: Securities To Be Sold"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1326	1620.11	49831298	04/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/01/2026	Restricted Stock Vesting	Issuer			1326	04/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Wolfe Repass 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	02/19/2026	21857	32427.05
Wolfe Repass 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	02/20/2026	12406	19179.67
Wolfe Repass 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	02/23/2026	4179	6192.86
Wolfe Repass 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	02/24/2026	13796	20285.64
Wolfe Repass 2942 North 24th Street Suite 115, #42035 Phoenix AZ 85016	Common	02/25/2026	5245	7958.76
Wolfe Repass 2942 North 24th Street, Suite 115 #42035 Phoenix AZ 85016	Common	02/26/2026	13675	20006.53
Wolfe Repass 2942 North 24th Street, Suite 115 #42035 Phoenix AZ 85016	Common	02/27/2026	9177	13575.54
Wolfe Repass 2942 North 24th Street Suite 115 #42035 Phoenix AZ 85016	Common	03/02/2026	11281	16052.86
Wolfe Repass 2942 North 24th Street Suite 115 #42035 Phoenix AZ 85016	Common	03/20/2026	176	219.35

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does FLD's Form 144 filing say about Wolfe Repass sales?

The filing lists multiple proposed sales by Wolfe Repass, showing specific trades such as 21,857 shares for $32,427.05 on 02/19/2026. It records several additional dates and share counts between 02/19/2026 and 03/20/2026.

Does the FLD filing show any shares issued to insiders (vesting)?

Yes — the filing records Restricted Stock Vesting of 1,326 shares on 04/01/2026 and classifies that event as compensation-related. That vesting is listed separately from the reported sales.

How large were the individual trades reported in FLD's Form 144?

Individual reported trades range from hundreds to tens of thousands of shares, for example 21,857 shares for $32,427.05 on 02/19/2026 and 12,406 shares for $19,179.67 on 02/20/2026, per the excerpt.

Does the Form 144 state the insider's remaining holdings after these sales?

The provided excerpt does not state post-transaction holdings, only the dates, share counts, and proceeds for the listed dispositions. Follow-up filings would be needed for updated ownership figures.